Information Library

Results for: Get to market faster - Our Expertise

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Understanding the Complexity of HTA Networks

    Presentation — November 27, 2011
    As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service.

  • Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.

    Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).

  • Using Real-Time Data to Drive Better Decisions, Faster

    White Paper — September 30, 2010
    This white paper examines the advantages afforded by access to real-time data during the course of a clinical trial.

  • Navigating Future Challenges in Alzheimer's Disease Trials

    White Paper — September 21, 2010
    Quintiles’ own Alzheimer’s experts, Amir Kalali, Roza Hayduk and Lynne Hughes, sum up the insights and discoveries that could lead to the next breakthrough for Alzheimer’s disease.

  • A Blueprint for Clinical / Commercial Convergence

    White Paper — August 5, 2010
    The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities.

  • Bridging Cultures

    Case Study — May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • FDA Requirements for Clinical Studies in Pediatric Patients

    White Paper — April 1, 2010
    FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy

  • Data-Driven Patient Recruitment

    White Paper — March 23, 2010
    Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials.

  • Regulations for Clinical Studies in Pediatric Patients in the European Union

    White Paper — March 10, 2010
    After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric

  • Chasing Influenza

    White Paper — November 30, 2009
    The rise in influenza strains like H1N1 — and the demand for new vaccines — signals a new era in vaccines. Learn how flu vaccines have evolved and where they’re headed.

Page 1 of 1 (10 results)

Subscribe to Email Based on Your Interests

Set preferences